GR3018674T3 - Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds - Google Patents
Treatment of hepatobiliary disease with 15-keto-prostaglandin compoundsInfo
- Publication number
- GR3018674T3 GR3018674T3 GR960400072T GR960400072T GR3018674T3 GR 3018674 T3 GR3018674 T3 GR 3018674T3 GR 960400072 T GR960400072 T GR 960400072T GR 960400072 T GR960400072 T GR 960400072T GR 3018674 T3 GR3018674 T3 GR 3018674T3
- Authority
- GR
- Greece
- Prior art keywords
- treatment
- keto
- hepatobiliary disease
- prostaglandin compounds
- hepatobiliary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27460689 | 1989-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3018674T3 true GR3018674T3 (en) | 1996-04-30 |
Family
ID=17544076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR960400072T GR3018674T3 (en) | 1989-10-20 | 1996-01-16 | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5096927A (el) |
| EP (1) | EP0424156B1 (el) |
| JP (1) | JPH03204816A (el) |
| KR (1) | KR0127297B1 (el) |
| AT (1) | ATE132749T1 (el) |
| CA (1) | CA2027814C (el) |
| DE (1) | DE69024744T2 (el) |
| DK (1) | DK0424156T3 (el) |
| ES (1) | ES2085898T3 (el) |
| GR (1) | GR3018674T3 (el) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE174221T1 (de) * | 1990-05-01 | 1998-12-15 | R Tech Ueno Ltd | Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten |
| CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
| AU740819B2 (en) * | 1997-10-13 | 2001-11-15 | Sucampo Ag | Portal hypertension inhibitor |
| NZ336960A (en) * | 1997-11-28 | 2001-02-23 | R Tech Ueno Ltd | Use of 15-keto-prostaglandin E compounds for the preparation of medicaments for use as endothelin antagonists |
| TWI225398B (en) * | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
| DE60139002D1 (de) | 2000-04-06 | 2009-07-30 | Sucampo Ag | Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält |
| TWI302100B (en) * | 2001-05-02 | 2008-10-21 | Sucampo Ag | Composition for treating drug-induced constipation |
| TWI331920B (en) * | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
| TWI263505B (en) | 2001-11-19 | 2006-10-11 | Sucampo Ag | Pharmaceutical composition comprising a C1C-2 channel opener |
| JP2010519177A (ja) * | 2007-02-27 | 2010-06-03 | スキャンポ・アーゲー | ミトコンドリアを保護するための組成物および方法 |
| US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4374856A (en) * | 1980-09-10 | 1983-02-22 | The Upjohn Company | Liver cytoprotection using PGE's |
| FR2517679A1 (fr) * | 1981-12-03 | 1983-06-10 | Synthelabo | Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique |
| JPS58164512A (ja) * | 1982-03-25 | 1983-09-29 | Ono Pharmaceut Co Ltd | プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤 |
| DE3401542A1 (de) * | 1984-01-18 | 1985-08-01 | Merck Patent Gmbh, 6100 Darmstadt | Schwefelhaltige 6-ketoprostaglandine |
| EP0153858A3 (en) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | The therapeutic use of prostaglandins |
| JPS62277352A (ja) * | 1986-01-30 | 1987-12-02 | Ono Pharmaceut Co Ltd | 新規な６−ケト−プロスタグランジンｅ１誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤 |
| CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
| CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
| CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
| ES2038289T3 (es) * | 1987-05-15 | 1993-07-16 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal. |
| ATE108330T1 (de) * | 1987-09-18 | 1994-07-15 | R Tech Ueno Ltd | Hypotensive okulare mittel. |
| ES2051862T3 (es) * | 1987-10-02 | 1994-07-01 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para producir un medicamento que tiene un efecto catartico. |
| JP2597629B2 (ja) * | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化 |
| AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
| JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
| JPH03101622A (ja) * | 1989-09-11 | 1991-04-26 | Green Cross Corp:The | 肝炎予防治療剤 |
-
1990
- 1990-10-17 CA CA002027814A patent/CA2027814C/en not_active Expired - Lifetime
- 1990-10-18 DE DE69024744T patent/DE69024744T2/de not_active Expired - Lifetime
- 1990-10-18 EP EP90311457A patent/EP0424156B1/en not_active Expired - Lifetime
- 1990-10-18 DK DK90311457.7T patent/DK0424156T3/da active
- 1990-10-18 AT AT90311457T patent/ATE132749T1/de not_active IP Right Cessation
- 1990-10-18 ES ES90311457T patent/ES2085898T3/es not_active Expired - Lifetime
- 1990-10-19 US US07/600,048 patent/US5096927A/en not_active Expired - Lifetime
- 1990-10-19 JP JP2282420A patent/JPH03204816A/ja active Granted
- 1990-10-20 KR KR1019900016811A patent/KR0127297B1/ko not_active IP Right Cessation
-
1996
- 1996-01-16 GR GR960400072T patent/GR3018674T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69024744D1 (de) | 1996-02-22 |
| ES2085898T3 (es) | 1996-06-16 |
| KR0127297B1 (ko) | 1998-04-01 |
| EP0424156B1 (en) | 1996-01-10 |
| US5096927A (en) | 1992-03-17 |
| EP0424156A3 (en) | 1992-04-22 |
| KR910007531A (ko) | 1991-05-30 |
| JPH0571568B2 (el) | 1993-10-07 |
| CA2027814A1 (en) | 1991-04-21 |
| DE69024744T2 (de) | 1996-05-23 |
| DK0424156T3 (da) | 1996-02-05 |
| EP0424156A2 (en) | 1991-04-24 |
| ATE132749T1 (de) | 1996-01-15 |
| CA2027814C (en) | 1996-07-30 |
| JPH03204816A (ja) | 1991-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3027666T3 (en) | Treatment of cataract with 15-keto-prostaglandin compounds | |
| GR3020902T3 (en) | Use of 15-keto-prostaglandin compound for improvement of encephalic function | |
| DE3779053D1 (el) | ||
| EP0455448A3 (en) | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | |
| ES2093774T3 (es) | Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. | |
| GR3019760T3 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
| EP0424156A3 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
| GR3026105T3 (en) | Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds | |
| EP0430552A3 (en) | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds | |
| SE8900875L (sv) | Osteoporosbehandling | |
| AU639322B2 (en) | Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds | |
| GR3022217T3 (en) | Treatment of cataract with prostacyclin compounds | |
| EP0261439A3 (en) | Medicament for curing arteriosclerosis, comprising pyrimido (2,1-b) benzothiazole derivative | |
| EP0405905A3 (en) | Use of isoxazolin-3-one derivatives as antidepressants | |
| AR245225A1 (es) | Composiciones para el tratamiento de cuero. |